Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement-Reference-Cited by-同舟云学术

Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement

Published:2013-10 Issue:10 Volume:23 Page:1211-1225
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Verburg Frederik A.¹,Luster Markus²,Cupini Cristina³,Chiovato Luca⁴,Duntas Leonidas⁵,Elisei Rossella⁶,Feldt-Rasmussen Ulla⁷,Rimmele Harald⁸,Seregni Ettore⁹,Smit Johannes W.A.¹⁰,Theimer Christian¹¹,Giovanella Luca¹²¹³

Affiliation:

1. Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany.

2. Department of Nuclear Medicine, University Hospital Ulm, Ulm, Germany.

3. Endocrine Outpatient Clinic, University Hospital Pisa, Pisa, Italy.

4. Department of Internal Medicine and Endocrinology, Salvatore Maugeri Foundation Research Hospital (IRCCS), University of Pavia Hospital, Pavia, Italy.

5. Endocrine Unit, Evgenidion Hospital, University of Athens Medical School, Athens, Greece.

6. Department of Endocrinology, University Hospital Pisa, Pisa, Italy.

7. Department of Endocrinology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.

8. Ohne Schilddrüse leben e.V., Thyroid Cancer Association (Bundesverband Schilddrüsenkrebs), Berlin, Germany.

9. Department of Endocrinology, Cancer Institute, Milan, Italy.

10. Department of Endocrinology, University Medical Center St. Radboud, Nijmegen, The Netherlands.

11. B·R·A·H·M·S GmbH, Thermo Fisher Scientific Inc., Hennigsdorf, Germany.

12. Department of Nuclear Medicine and PET Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

13. Department of Laboratory Medicine EOLAB, Cantonal Hospital Authority, Bellinzona, Switzerland.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2012.0606

Reference124 articles.

1. Disappearance of Humoral Thyroid Autoimmunity after Complete Removal of Thyroid Antigens

2. Thyroid autoantibodies in thyroid cancer: Incidence and relationship with tumour outcome

3. False-positive results corrected by the use of heterophilic antibody-blocking reagent in thyroglobulin immunoassays

4. Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma

5. Phantoms in the Assay Tube: Heterophile Antibody Interferences in Serum Thyroglobulin Assays

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons Learned: Establishing a CLIA-Equivalent Laboratory for Targeted Mass Spectrometry Assays – Navigating the Transition from Research to Clinical Practice;2023-11-28

2. Trattamento con radioiodio nel paziente con carcinoma differenziato della tiroide a basso rischio: sì, no, forse?;L'Endocrinologo;2023-09-21

3. Thyroglobulin immunoassay with a fully automated pretreatment process provides accurate thyroglobulin values in anti-thyroglobulin antibody positive specimens;Clinical Biochemistry;2023-08

4. Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus;European Journal of Endocrinology;2023-08

5. Modified dynamic risk stratification system further predicts individual outcome in patients with intermediate-risk papillary thyroid cancer;Annales d'Endocrinologie;2023-04